A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir - Contacts and Locations

A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir

This study has been completed.

Study NCT00002423. Last updated on June 23, 2005. Information provided by NIH AIDS Clinical Trials Information Service

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002423

Locations


United States, California
	Saint Francis Mem Hosp
	San Francisco, California, United States, 94109

United States, District of Columbia
	Georgetown Univ Med Ctr
	Washington, District of Columbia, United States, 20007

United States, Florida
	IDC Research Initiative
	Altamonte Springs, Florida, United States, 32701

United States, Maryland
	Natl Institute of Allergy and Infectious Diseases
	Bethesda, Maryland, United States, 20892

United States, Missouri
	Kansas City AIDS Research Consortium
	Kansas City, Missouri, United States, 64111

United States, New York
	Bentley-Salick Med Practice
	New York, New York, United States, 10011

United States, Oklahoma
	Associates in Med and Mental Health
	Tulsa, Oklahoma, United States, 74114

United States, Oregon
	Portland Veterans Adm Med Ctr / Rsch & Education Grp
	Portland, Oregon, United States, 972109951

Sponsors and Collaborators

Glaxo Wellcome